US Edition
News from Pharmaphorum
If you want to know if Pharmaphorum is credible or reliable, look no further. We rank Pharmaphorum as High factuality. Find out more about our methodology here.
Media Bias Ratings
Average Bias Rating:
Center
Center
byAd Fontes MediaDo you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Pharmaphorum News
Business · United StatesThe U.S. Food and Drug Administration on Monday approved the first oral medication to treat obesity — a pill version of the weight-loss drug Wegovy. The pill contains semaglutide, the same active ingredient as injectable Wegovy and Ozempic.See the Story
FDA Approves First Daily Pill for Weight Loss Treatment
63% Center coverage: 257 sources
Business & Markets · United StatesSanofi will buy U.S. vaccines company Dynavax Technologies for around $2.2 billion (1.9 billion euros), the French drugmaker said on Wednesday, a deal that will give it access to an approved hepatitis B vaccine.See the Story
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
66% Center coverage: 15 sources
Moderna · United StatesModerna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover some of the funding that was cut off when the federal government canceled hundreds of millions of dollars in contracts.
See the Story
Moderna receives $54.3M investment for bird flu vaccine, covering axed federal mRNA contracts
100% Center coverage: 15 sources
